Literature DB >> 18726886

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.

Shigeki Kusamura1, Elias Dominique, Dario Baratti, Rami Younan, Marcello Deraco.   

Abstract

At the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Conflicting points concerning drugs, carrier solution and optimal temperature for hyperthermic intraperitoneal chemotherapy (HIPEC) were discussed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18726886     DOI： 10.1002/jso.21051

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  28 in total

Review 1.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 2.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.

Authors:  Loek A W de Jong; Fortuné M K Elekonawo; Philip R de Reuver; Andre J A Bremers; Johannes H W de Wilt; Frank G A Jansman; Rob Ter Heine; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

3.  Splenectomy revisited in 2011: Impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Nancy Deslauriers; Harold Olney; Rami Younan
Journal:  J Gastrointest Oncol       Date:  2011-06

4.  Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy.

Authors:  S J Valle; N A Alzahrani; W Liauw; P H Sugarbaker; A Bhatt; D L Morris
Journal:  Indian J Surg Oncol       Date:  2016-02-05

5.  Peritoneal carcinomatosis of colorectal origin.

Authors:  Antonio Macrì; Edoardo Saladino; Vincenzo Bartolo; Vincenzo Adamo; Giuseppe Altavilla; Epifanio Mondello; Giovanni Condemi; Angelo Sinardi; Ciro Famulari
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

6.  Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.

Authors:  Deepa Magge; Mazen S Zenati; Frances Austin; Arun Mavanur; Magesh Sathaiah; Lekshmi Ramalingam; Heather Jones; Amer H Zureikat; Matthew Holtzman; Steven Ahrendt; James Pingpank; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2013-12-10       Impact factor: 5.344

Review 7.  Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy.

Authors:  Martin D Goodman; Sarah McPartland; Danielle Detelich; Muhammad Wasif Saif
Journal:  J Gastrointest Oncol       Date:  2016-02

8.  Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion.

Authors:  Ibrahim Nassour; Patricio M Polanco
Journal:  Curr Colorectal Cancer Rep       Date:  2017-04-08

9.  Implementation of a standardized HIPEC protocol improves outcome for peritoneal malignancy.

Authors:  Anke M J Kuijpers; Arend G J Aalbers; Simon W Nienhuijs; Ignace H J T de Hingh; Marinus J Wiezer; Bert van Ramshorst; Robert J van Ginkel; Klaas Havenga; Wilma D Heemsbergen; Michael Hauptmann; Victor J Verwaal
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

10.  A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.

Authors:  Edward A Levine; Konstantinos I Votanopoulos; Perry Shen; Greg Russell; Joyce Fenstermaker; Paul Mansfield; David Bartlett; John H Stewart
Journal:  J Am Coll Surg       Date:  2018-01-10       Impact factor: 6.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.